Some researchers also investigate combination approaches, pairing GLP-1 agonists with other peptides that target complementary pathways
Animal reproduction studies with semaglutide have shown embryofetal toxicity, including structural abnormalities, at exposures below those expected at therapeutic doses in humans
revealed a link between semaglutidea popular glucagon-like peptide 1 receptor agonist (GLP-1RA) used to treat type 2 diabetes and obesityand an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION)
When using semaglutide drug, its important to be aware of how it might affect kidney function and cardiovascular health
STUDY DESIGNS SUSTAIN 4: Head-to-head vs Lantus (insulin glargine U-100) 1,9 Study design: 30-week, randomized, open-label, active-controlled, parallel-group, multinational, multicenter trial to evaluate the efficacy and safety of Ozempic injection vs insulin glargine U-100